A comprehensive coverage insurance for cells: revealing links between ribosome collisions, stress responses and mRNA surveillance

RNA Biol. 2022;19(1):609-621. doi: 10.1080/15476286.2022.2065116. Epub 2021 Dec 31.

Abstract

Cells of metazoans respond to internal and external stressors by activating stress response pathways that aim for re-establishing cellular homoeostasis or, if this cannot be achieved, triggering programmed cell death. Problems during translation, arising from defective mRNAs, tRNAs, ribosomes or protein misfolding, can activate stress response pathways as well as mRNA surveillance and ribosome quality control programs. Recently, ribosome collisions have emerged as a central signal for translational stress and shown to elicit different stress responses. Here, we review our current knowledge about the intricate mutual connections between ribosome collisions, stress response pathways and mRNA surveillance. A central factor connecting the sensing of collided ribosomes with degradation of the nascent polypeptides, dissociation of the stalled ribosomes and degradation of the mRNA by no-go or non-stop decay is the E3-ligase ZNF598. We tested whether ZNF598 also plays a role in nonsense-mediated mRNA decay (NMD) but found that it is dispensable for this translation termination-associated mRNA surveillance pathway, which in combination with other recent data argues against stable ribosome stalling at termination codons being the NMD-triggering signal.

Keywords: ISR; NGD; NMD; NSD; RQC; Stress response; UPR; ZNF598; mRNA surveillance; quality control; ribosome; ribosome collisions; ribotoxic stress; translation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Insurance*
  • Nonsense Mediated mRNA Decay
  • Protein Biosynthesis
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Ribosomes* / metabolism

Substances

  • RNA, Messenger

Grants and funding

S.D. is supported by a grant of the Novartis Foundation for Biomedical Research. The research in the lab of O.M. is further supported by the National Center of Competence in Research (NCCR) on RNA & Disease funded by the Swiss National Science Foundation (SNSF; 51NF40-182880), by the SNSF grant 310030-204161, and by the Kanton Bern.